Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 336

1.

T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer.

Fabi A, Alesini D, Valle E, Moscetti L, Caputo R, Caruso M, Carbognin L, Ciccarese M, La Verde N, Arpino G, Cannita K, Paris I, Santini D, Montemurro F, Russillo M, Ferretti G, Filippelli G, Rossello R, Fabbri A, Zambelli A, Leonardi V, D'Ottavio AM, Nisticò C, Stani S, Giampaglia M, Scandurra G, Catania G, Malaguti P, Giannarelli D, Cognetti F.

Breast. 2018 Jul 12;41:137-143. doi: 10.1016/j.breast.2018.07.004. [Epub ahead of print]

PMID:
30092500
2.

Long-term follow up of metastatic melanoma patients treated with Thymosin alpha-1: investigating immune checkpoints synergy.

Danielli R, Cisternino F, Giannarelli D, Calabrò L, Camerini R, Savelli V, Bova G, Dragonetti R, Di Giacomo AM, Altomonte M, Maio M.

Expert Opin Biol Ther. 2018 Jul;18(sup1):77-83. doi: 10.1080/14712598.2018.1494717.

PMID:
30063847
3.

Prospective evaluation of metabolic syndrome and its features in a single-center series of hematopoietic stem cell transplantation recipients.

Annaloro C, Airaghi L, Giannarelli D, Mometto G, Orsatti A, Saporiti G, Grifoni FI, Baldini M, Tagliaferri E, Vincenti D, Maira D, Onida F, Cortelezzi A.

Ann Hematol. 2018 Jul 27. doi: 10.1007/s00277-018-3452-0. [Epub ahead of print]

PMID:
30054704
4.

Use of nivolumab in elderly patients with advanced squamous non-small-cell lung cancer: results from the Italian cohort of an expanded access programme.

Grossi F, Crinò L, Logroscino A, Canova S, Delmonte A, Melotti B, Proto C, Gelibter A, Cappuzzo F, Turci D, Gamucci T, Antonelli P, Marchetti P, Santoro A, Giusti S, Di Costanzo F, Giustini L, Del Conte A, Livi L, Giannarelli D, de Marinis F.

Eur J Cancer. 2018 Sep;100:126-134. doi: 10.1016/j.ejca.2018.05.015. Epub 2018 Jul 13.

PMID:
30014881
5.

Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab.

Capone M, Giannarelli D, Mallardo D, Madonna G, Festino L, Grimaldi AM, Vanella V, Simeone E, Paone M, Palmieri G, Cavalcanti E, Caracò C, Ascierto PA.

J Immunother Cancer. 2018 Jul 16;6(1):74. doi: 10.1186/s40425-018-0383-1.

6.

Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme.

De Giorgi U, Cartenì G, Giannarelli D, Basso U, Galli L, Cortesi E, Caserta C, Pignata S, Sabbatini R, Bearz A, Buti S, Lo Re G, Berruti A, Bracarda S, Cognetti F, Rastelli F, Fornarini G, Porta C, Turci D, Sternberg CN, Procopio G; Italian Nivolumab Renal Cell Cancer Early Access Program Group.

BJU Int. 2018 Jun 29. doi: 10.1111/bju.14461. [Epub ahead of print]

PMID:
29956884
7.

Do immune checkpoint inhibitors need new studies methodology?

Ferrara R, Pilotto S, Caccese M, Grizzi G, Sperduti I, Giannarelli D, Milella M, Besse B, Tortora G, Bria E.

J Thorac Dis. 2018 May;10(Suppl 13):S1564-S1580. doi: 10.21037/jtd.2018.01.131. Review.

8.

The Effectiveness of the Sport "Dragon Boat Racing" in Reducing the Risk of Lymphedema Incidence: An Observational Study.

Iacorossi L, Gambalunga F, Molinaro S, De Domenico R, Giannarelli D, Fabi A.

Cancer Nurs. 2018 Jun 22. doi: 10.1097/NCC.0000000000000615. [Epub ahead of print]

PMID:
29933309
9.

Predictors of atrial fibrillation in ibrutinib-treated CLL patients: a prospective study.

Reda G, Fattizzo B, Cassin R, Mattiello V, Tonella T, Giannarelli D, Massari F, Cortelezzi A.

J Hematol Oncol. 2018 Jun 11;11(1):79. doi: 10.1186/s13045-018-0626-0.

10.

Negative prognostic factors and resulting clinical outcome in patients with metastatic renal cell carcinoma included in the Italian nivolumab-expanded access program.

Bracarda S, Galli L, Maruzzo M, Lo Re G, Buti S, Favaretto A, Di Costanzo F, Sacco C, Merlano M, Mucciarini C, Zafarana E, Romito S, Maestri A, Giorgio CG, Ionta MT, Turci D, De Giorgi U, Procopio G, Cortesi E, Giannarelli D, Porta C.

Future Oncol. 2018 Jun;14(14):1347-1354. doi: 10.2217/fon-2017-0570. Epub 2018 May 18.

PMID:
29774766
11.

Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study.

Calabrò L, Morra A, Giannarelli D, Amato G, D'Incecco A, Covre A, Lewis A, Rebelatto MC, Danielli R, Altomonte M, Di Giacomo AM, Maio M.

Lancet Respir Med. 2018 Jun;6(6):451-460. doi: 10.1016/S2213-2600(18)30151-6. Epub 2018 May 15.

PMID:
29773326
12.

Chronic lymphocytic leukemia international prognostic index (CLL-IPI) in patients receiving chemoimmuno or targeted therapy: a systematic review and meta-analysis.

Molica S, Giannarelli D, Mirabelli R, Levato L, Shanafelt TD.

Ann Hematol. 2018 May 8. doi: 10.1007/s00277-018-3350-5. [Epub ahead of print] No abstract available.

PMID:
29740683
13.

Italian Nivolumab Expanded Access Program in Nonsquamous Non-Small Cell Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients.

Garassino MC, Gelibter AJ, Grossi F, Chiari R, Soto Parra H, Cascinu S, Cognetti F, Turci D, Blasi L, Bengala C, Mini E, Baldini E, Quadrini S, Ceresoli GL, Antonelli P, Vasile E, Pinto C, Fasola G, Galetta D, Macerelli M, Giannarelli D, Lo Russo G, de Marinis F.

J Thorac Oncol. 2018 Aug;13(8):1146-1155. doi: 10.1016/j.jtho.2018.04.025. Epub 2018 May 3.

PMID:
29730379
14.

Supracricoid partial laryngectomy for radiorecurrent laryngeal cancer: a systematic review of the literature and meta-analysis.

De Virgilio A, Pellini R, Mercante G, Cristalli G, Manciocco V, Giannarelli D, Spriano G.

Eur Arch Otorhinolaryngol. 2018 Jul;275(7):1671-1680. doi: 10.1007/s00405-018-4986-4. Epub 2018 Apr 30. Review.

PMID:
29713885
15.

Anaplastic lymphoma kinase immunohistochemistry scores do not predict sensitivity to crizotinib in fluorescence in situ hybridization-positive non-small cell lung cancer patients.

Metro G, Giannarelli D, Sidoni A, Chiari R, Bellezza G.

Int J Biol Markers. 2018 Apr 1:1724600818754763. doi: 10.1177/1724600818754763. [Epub ahead of print] No abstract available.

PMID:
29683065
16.

Inflatable Penile Prosthesis Placement, Scratch Technique and Postoperative Vacuum Therapy as a Combined Approach to Definitive Treatment of Peyronie's Disease.

Antonini G, De Berardinis E, Del Giudice F, Busetto GM, Lauretti S, Fragas R, Chung BI, Conti SL, Giannarelli D, Sperduti I, Gross MS, Perito PE.

J Urol. 2018 Apr 17. pii: S0022-5347(18)43028-5. doi: 10.1016/j.juro.2018.04.060. [Epub ahead of print]

PMID:
29678456
17.

[The impact of Reiki on side effects in patients with head-neck neoplasia undergoing radiotherapy: a pilot study].

Iacorossi L, Di Ridolfi P, Bigiarini L, Giannarelli D, Sanguineti G.

Prof Inferm. 2017 Oct-Dec;70(3):214-221. doi: 10.7429/pi.2017.704214. Italian.

PMID:
29460558
18.

Lenograstim 5 µg/kg is not superior to biosimilar filgrastim 10 µg/kg in lymphoma patients undergoing peripheral blood stem cell mobilization after chemotherapy: preliminary results from a prospective randomized study.

Marchesi F, Vacca M, Giannarelli D, Ipsevich F, Pandolfi A, Gumenyuk S, Renzi D, Palombi F, Pisani F, Romano A, Spadea A, Papa E, Canfora M, Pierelli L, Mengarelli A.

Transfusion. 2018 May;58(5):1143-1148. doi: 10.1111/trf.14533. Epub 2018 Feb 15.

PMID:
29446445
19.

BEAM vs FEAM high-dose chemotherapy: retrospective study in lymphoma patients undergoing autologous stem cell transplant.

Marchesi F, Capria S, Giannarelli D, Trisolini SM, Ansuinelli M, Caputo MD, Serrao A, Gumenyuk S, Renzi D, Pupo L, Palombi F, Provenzano I, Di Rocco A, Pisani F, Romano A, Spadea A, Papa E, Canfora M, Cantonetti M, Mengarelli A.

Bone Marrow Transplant. 2018 Aug;53(8):1051-1054. doi: 10.1038/s41409-018-0120-x. Epub 2018 Feb 13. No abstract available.

PMID:
29440737
20.

Association between Helicobacter pylori infection and vulvar lichen sclerosus: a clinical comparative study.

Basile S, Pinelli S, Benedetti Panici P, Angioli R, Plotti F, Giannarelli D, Fossati R, Rosati CM, Salerno MG.

Eur J Dermatol. 2018 Apr 1;28(2):226-227. doi: 10.1684/ejd.2017.3207. No abstract available.

PMID:
29336317
21.

Short course hypofractionated whole breast irradiation after conservative surgery: a single institution phase II study.

Pinnarò P, Giordano C, Farneti A, Faiella A, Iaccarino G, Landoni V, Giannarelli D, Vici P, Strigari L, Sanguineti G.

J Exp Clin Cancer Res. 2017 Dec 27;36(1):191. doi: 10.1186/s13046-017-0640-z.

22.

Estrogen treatment in infertile women with premature ovarian insufficiency in transitional phase: a retrospective analysis.

Pinelli S, Artini PG, Basile S, Obino MER, Sergiampietri C, Giannarelli D, Simi G, Cela V.

J Assist Reprod Genet. 2018 Mar;35(3):475-482. doi: 10.1007/s10815-017-1096-y. Epub 2017 Dec 5.

PMID:
29204869
23.

Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab.

Morello S, Capone M, Sorrentino C, Giannarelli D, Madonna G, Mallardo D, Grimaldi AM, Pinto A, Ascierto PA.

J Transl Med. 2017 Dec 4;15(1):244. doi: 10.1186/s12967-017-1348-8.

24.

Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?

Fabi A, Giannarelli D, Moscetti L, Santini D, Zambelli A, Laurentiis M, Caruso M, Generali D, Valle E, Leonardi V, Cannita K, Arpino G, Filippelli G, Ferretti G, Giampaglia M, Montemurro F, Nisticò C, Gasparro S, Cognetti F.

Future Oncol. 2017 Dec;13(30):2791-2797. doi: 10.2217/fon-2017-0336. Epub 2017 Nov 28.

PMID:
29182361
25.

Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer.

Metro G, Passaro A, Lo Russo G, Bonanno L, Giusti R, Gregorc V, Capelletto E, Martelli O, Cecere FL, Giannarelli D, Luciani A, Bearz A, Tuzi A, Scotti V, Tonini G, Galetta D, Carta A, Soto Parra H, Rebonato A, Morabito A, Chiari R.

Future Oncol. 2018 Feb;14(4):353-361. doi: 10.2217/fon-2017-0441. Epub 2017 Nov 14.

PMID:
29135281
26.

Chronic lymphocytic leukemia international prognostic index: a systematic review and meta-analysis.

Molica S, Giannarelli D, Mirabelli R, Levato L, Kay NE, Shanafelt TD.

Blood. 2018 Jan 18;131(3):365-368. doi: 10.1182/blood-2017-09-806034. Epub 2017 Oct 30. No abstract available.

PMID:
29084773
27.

Efficacy and safety of T-DM1 in the 'common-practice' of HER2+ advanced breast cancer setting: a multicenter study.

Fabi A, De Laurentiis M, Caruso M, Valle E, Moscetti L, Santini D, Cannita K, Carbognin L, Ciccarese M, Rossello R, Arpino G, Leonardi V, Montemurro F, La Verde N, Generali D, Zambelli A, Scandurra G, Russillo M, Paris I, D'Ottavio AM, Filippelli G, Giampaglia M, Stani S, Fabbri A, Alesini D, Cianniello D, Giannarelli D, Cognetti F.

Oncotarget. 2017 Mar 18;8(38):64481-64489. doi: 10.18632/oncotarget.16373. eCollection 2017 Sep 8.

28.

Propolis in the prevention of oral mucositis in breast cancer patients receiving adjuvant chemotherapy: A pilot randomised controlled trial.

Piredda M, Facchinetti G, Biagioli V, Giannarelli D, Armento G, Tonini G, De Marinis MG.

Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12757. Epub 2017 Aug 25.

PMID:
28840622
29.

Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients.

Maccalli C, Giannarelli D, Chiarucci C, Cutaia O, Giacobini G, Hendrickx W, Amato G, Annesi D, Bedognetti D, Altomonte M, Danielli R, Calabrò L, Di Giacomo AM, Marincola FM, Parmiani G, Maio M.

Oncoimmunology. 2017 May 8;6(7):e1323618. doi: 10.1080/2162402X.2017.1323618. eCollection 2017.

30.

Patterns of care of brain tumor-related epilepsy. A cohort study done in Italian Epilepsy Center.

Maschio M, Beghi E, Casazza MML, Colicchio G, Costa C, Banfi P, Quadri S, Aloisi P, Giallonardo AT, Buttinelli C, Pauletto G, Striano S, Salmaggi A, Terenzi R, Daniele O, Crichiutti G, Paladin F, Rossi R, Prato G, Vigevano F, De Simone R, Ricci F, Saladini M, Monti F, Casellato S, Zanoni T, Giannarelli D, Avanzini G, Aguglia U; BTRE Study Group.

PLoS One. 2017 Jul 17;12(7):e0180470. doi: 10.1371/journal.pone.0180470. eCollection 2017.

31.

Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.

Maschio M, Zarabla A, Maialetti A, Fabi A, Vidiri A, Villani V, Giannarelli D.

Epilepsy Behav. 2017 Aug;73:83-89. doi: 10.1016/j.yebeh.2017.05.031. Epub 2017 Jun 14.

PMID:
28623754
32.

Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer.

Marucci L, Farneti A, Di Ridolfi P, Pinnaro P, Pellini R, Giannarelli D, Vici P, Conte M, Landoni V, Sanguineti G.

Head Neck. 2017 Sep;39(9):1761-1769. doi: 10.1002/hed.24832. Epub 2017 May 31.

PMID:
28560780
33.

The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC).

Nicolazzo C, Busetto GM, Del Giudice F, Sperduti I, Giannarelli D, Gradilone A, Gazzaniga P, de Berardinis E, Raimondi C.

J Cancer Res Clin Oncol. 2017 Oct;143(10):1971-1976. doi: 10.1007/s00432-017-2449-8. Epub 2017 May 29.

PMID:
28555356
34.

Laser-assisted hatching of human embryos: may two alternative approaches (thinning versus drilling) impact on implant rate?

Padula F, Capriglione S, Iaconianni P, Gatti S, Lippa A, Minutolo SE, Giannarelli D, Giorlandino C.

Lasers Med Sci. 2017 Sep;32(7):1663-1666. doi: 10.1007/s10103-017-2242-6. Epub 2017 May 25. No abstract available.

PMID:
28547074
35.

Erratum to: Elaboration of a nomogram to predict nonsentinel node status in breast cancer patients with positive sentinel node, intraoperatively assessed with one step nucleic amplification: Retrospective and validation phase.

Di Filippo F, Di Filippo S, Ferrari AM, Antonetti R, Battaglia A, Becherini F, Bernet L, Boldorini R, Bouteille C, Buglioni S, Burelli P, Cano R, Canzonieri V, Chiodera P, Cirilli A, Coppola L, Drago S, Di Tommaso L, Fenaroli P, Franchini R, Gianatti A, Giannarelli D, Giardina C, Godey F, Grassi MM, Grassi GB, Laws S, Massarut S, Naccarato G, Natalicchio MI, Orefice S, Palmieri F, Perin T, Roncella M, Roncalli MG, Rulli A, Sidoni A, Tinterri C, Truglia MC, Sperduti I.

J Exp Clin Cancer Res. 2017 May 16;36(1):69. doi: 10.1186/s13046-017-0540-2. No abstract available.

36.

The course of cancer related fatigue up to ten years in early breast cancer patients: What impact in clinical practice?

Fabi A, Falcicchio C, Giannarelli D, Maggi G, Cognetti F, Pugliese P.

Breast. 2017 Aug;34:44-52. doi: 10.1016/j.breast.2017.04.012. Epub 2017 May 11.

37.

Zonisamide in Brain Tumor-Related Epilepsy: An Observational Pilot Study.

Maschio M, Dinapoli L, Zarabla A, Maialetti A, Giannarelli D, Fabi A, Vidiri A, Cantelmi T.

Clin Neuropharmacol. 2017 May/Jun;40(3):113-119. doi: 10.1097/WNF.0000000000000218.

PMID:
28452903
38.

Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma.

Simeone E, Grimaldi AM, Festino L, Giannarelli D, Vanella V, Palla M, Curvietto M, Esposito A, Palmieri G, Mozzillo N, Ascierto PA.

Oncoimmunology. 2017 Jan 19;6(3):e1283462. doi: 10.1080/2162402X.2017.1283462. eCollection 2017.

39.

Chronic lymphocytic leukemia and prognostic models: A bridge between clinical and biological markers.

Reda G, Cassin R, Fattizzo B, Giannarelli D, Mattiello V, Barcellini W, Cortelezzi A.

Am J Hematol. 2017 Jul;92(7):E135-E137. doi: 10.1002/ajh.24755. Epub 2017 May 26. No abstract available.

40.

Meeting report: Vitiligo Global Issues Consensus Conference Workshop "Outcome measurement instruments" and Vitiligo International Symposium, Rome, Nov 30-Dec 3rd.

van Geel N, Boniface K, Seneschal J, Jacquemin C, Speeckaert R, Wolkerstorfer A, Bekkenk M, Lommerts JE, Hamzavi I, Pandya A, Eleftheriadou V, Ezzedine K, Giannarelli D, Gnarra M, Sperduti I, Prinsen C, Harris J, Taieb A, Picardo M.

Pigment Cell Melanoma Res. 2017 Jul;30(4):436-443. doi: 10.1111/pcmr.12593. Epub 2017 Jun 13. No abstract available.

PMID:
28379638
41.

Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab.

Ferrucci PF, Ascierto PA, Pigozzo J, Del Vecchio M, Maio M, Antonini Cappellini GC, Guidoboni M, Queirolo P, Savoia P, Mandalà M, Simeone E, Valpione S, Altomonte M, Spagnolo F, Cocorocchio E, Gandini S, Giannarelli D, Martinoli C.

Ann Oncol. 2018 Feb 1;29(2):524. doi: 10.1093/annonc/mdx059. No abstract available.

PMID:
28379318
42.

The Time Course of Diagnostic Delay in Inflammatory Bowel Disease Over the Last Sixty Years: An Italian Multicentre Study.

Cantoro L, Di Sabatino A, Papi C, Margagnoni G, Ardizzone S, Giuffrida P, Giannarelli D, Massari A, Monterubbianesi R, Lenti MV, Corazza GR, Kohn A.

J Crohns Colitis. 2017 Aug 1;11(8):975-980. doi: 10.1093/ecco-jcc/jjx041.

PMID:
28333328
43.

Reliability of six prognostic models to predict time-to-first-treatment in patients with chronic lymphocytic leukaemia in early phase.

Molica S, Giannarelli D, Mirabelli R, Levato L, Gentile M, Morabito F, Montserrat E.

Am J Hematol. 2017 Jun;92(6):E91-E93. doi: 10.1002/ajh.24707. Epub 2017 Mar 24. No abstract available.

44.

The Prognostic Role of Circulating Tumor Cells (CTC) in High-risk Non-muscle-invasive Bladder Cancer.

Busetto GM, Ferro M, Del Giudice F, Antonini G, Chung BI, Sperduti I, Giannarelli D, Lucarelli G, Borghesi M, Musi G, de Cobelli O, De Berardinis E.

Clin Genitourin Cancer. 2017 Aug;15(4):e661-e666. doi: 10.1016/j.clgc.2017.01.011. Epub 2017 Jan 18.

PMID:
28188046
45.

Elaboration of a nomogram to predict nonsentinel node status in breast cancer patients with positive sentinel node, intraoperatively assessed with one step nucleic amplification: Retrospective and validation phase.

Di Filippo F, Di Filippo S, Ferrari AM, Antonetti R, Battaglia A, Becherini F, Bernet L, Boldorini R, Bouteille C, Buglioni S, Burelli P, Cano R, Canzonieri V, Chiodera P, Cirilli A, Coppola L, Drago S, Di Tommaso L, Fenaroli P, Franchini R, Gianatti A, Giannarelli D, Giardina C, Godey F, Grassi MM, Grassi GB, Laws S, Massarut S, Naccarato G, Natalicchio MI, Orefice S, Palmieri F, Perin T, Roncella M, Roncalli MG, Rulli A, Sidoni A, Tinterri C, Truglia MC, Sperduti I.

J Exp Clin Cancer Res. 2016 Dec 8;35(1):193. doi: 10.1186/s13046-016-0460-6. Erratum in: J Exp Clin Cancer Res. 2017 May 16;36(1):69.

46.

Adherence to Oral Administration of Endocrine Treatment in Patients With Breast Cancer: A Qualitative Study.

Iacorossi L, Gambalunga F, Fabi A, Giannarelli D, Marchetti A, Piredda M, De Marinis MG.

Cancer Nurs. 2018 Jan/Feb;41(1):E57-E63. doi: 10.1097/NCC.0000000000000452.

PMID:
27922917
47.

Assessing time to first treatment in early chronic lymphocytic leukemia (CLL): a comparative performance analysis of five prognostic models with inclusion of CLL-international prognostic index (CLL-IPI).

Molica S, Giannarelli D, Levato L, Mirabelli R, Gentile M, Morabito F.

Leuk Lymphoma. 2017 Jul;58(7):1736-1739. doi: 10.1080/10428194.2016.1257791. Epub 2016 Nov 22. No abstract available.

PMID:
27875912
48.

Temozolomide low-dose chemotherapy in newly diagnosed low-grade gliomas: activity, safety, and long-term follow-up.

Villani V, Merola R, Vidiri A, Fabi A, Carosi M, Giannarelli D, Marucci L, Maschio M, Carapella CM, Pace A.

Tumori. 2017 May 12;103(3):255-260. doi: 10.5301/tj.5000565. Epub 2016 Sep 22.

PMID:
27716874
50.

The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.

Molica S, Shanafelt TD, Giannarelli D, Gentile M, Mirabelli R, Cutrona G, Levato L, Di Renzo N, Di Raimondo F, Musolino C, Angrilli F, Famà A, Recchia AG, Chaffee KG, Neri A, Kay NE, Ferrarini M, Morabito F.

Am J Hematol. 2016 Nov;91(11):1090-1095. doi: 10.1002/ajh.24493. Epub 2016 Aug 8.

Supplemental Content

Loading ...
Support Center